CDH2 and neoplasm: Also, several studies have shown that one of the hallmarks of tumor progression and EMT is the gain of N-cadherin expression by tumor cells, which may or may not be accompanied by the concomitant loss of E-cadherin expression, a phenomenon commonly referred to as cadherin switching [58,63,64,67].